Skip to main
HNGE

HNGE Stock Forecast & Price Target

HNGE Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 33%
Buy 60%
Hold 7%
Sell 0%
Strong Sell 0%

Bulls say

Hinge Health is a rapidly growing digital healthcare company with a strong focus on female health and utilizing AI technology for personalized and cost-effective care. With an expanding suite of services and positive revenue projections, Hinge Health is poised for continued success in the fully insured and SMB markets. While there are some potential risks, the company's strong metrics and innovative approach make it a top investment opportunity in the growing digital health industry.

Bears say

Hinge Health is a company that has seen an increase in key metrics such as revenue and profitability due to strong implementation of AI technology in their product development. However, management views go-to-market functions as the limiting factor to growth, indicating potential risks in achieving their revised target model. While early proof points for their new product, HingeSelect, have been positive, there are still risks to their rating and price target, including client losses and potential margin compression. Also, the post-IPO share lockup could lead to downward pressure on their stock price.

HNGE has been analyzed by 15 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 60% recommend Buy, 7% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Hinge Health Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Hinge Health Inc (HNGE) Forecast

Analysts have given HNGE a Buy based on their latest research and market trends.

According to 15 analysts, HNGE has a Buy consensus rating as of Aug 8, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $92.93, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $92.93, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Hinge Health Inc (HNGE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.